drugset / Trial / NCT03515382

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers

NCT03515382

Phase 1 Completed 18 enrolled Lakefront Biotherapeutics NV
RandomizedCrossoverOpen-labelBasic science

Summary

The sponsor wants to investigate how well the test medicine is taken up by the body when given alongside two other already approved medicines. This kind of study is known as a drug-drug interaction study. In this case the other medicines are itraconazole and voriconazole. The sponsor will also look at the safety and tolerability of the test medicine when taken alone, and when taken with the approved medicines.

Timeline

Start
2018-03-16
Primary completion
2018-06-01
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject Voriconazole Small molecule Oral
Subject ZIRITAXESTAT Small molecule Oral

Indications

No indication recorded.